Mithra announces today the results of its initial public offering of new shares, with admission to trading of all of its shares on the regulated market of Euronext Brussels, launched on 18 June 2015.
Mithra announces today the results of its initial public offering of new shares, with admission to trading of all of its shares on the regulated market of Euronext Brussels, launched on 18 June 2015.
Mithra (Euronext: MITRA) is a Belgian biotech company dedicated to transforming women’s health by offering new choices through innovation, with a particular focus on contraception and menopause.
Mithra (Headquarter)
Rue Saint-Georges 5
4000 Liège
Belgium
+32 (0)4 349 28 22
info@mithra.com
Mithra CDMO
Rue de l’Expansion 57
4400 Flémalle
Belgium
+32 (0)4 353 37 00
info@mithracdmo.com